Medtronic (MDT) Cash & Current Investments (2013 - 2026)

Medtronic (MDT) has 14 years of Cash & Current Investments data on file, last reported at $9.2 billion in Q2 2026.

• For the quarter ending Q2 2026, Cash & Current Investments rose 2.84% year-over-year to $9.2 billion; the trailing twelve-month figure through Apr 2026 stood at $9.2 billion (up 2.84% YoY), and the FY2026 full-year result was $9.2 billion, up 2.84% from the prior year.
• Cash & Current Investments grew to $9.2 billion in Q2 2026, from $8.4 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $11.4 billion in Q4 2022 to a low of $7.7 billion in Q4 2023.
• A 5-year average of $8.9 billion and a median of $8.3 billion in 2024 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments plunged 32.34% in 2023 and climbed 11.99% in 2025, its largest moves.
• Tracing MDT's Cash & Current Investments over 5 years: stood at $11.4 billion in 2022, then sank by 32.34% to $7.7 billion in 2023, then grew by 3.3% to $8.0 billion in 2024, then grew by 4.23% to $8.3 billion in 2025, then rose by 10.72% to $9.2 billion in 2026.
• Business Quant data shows MDT's Cash & Current Investments at $9.2 billion in Q2 2026, $8.4 billion in Q1 2026, and $8.3 billion in Q4 2025.